1361569-10-9

Basic information

• Product Name: 6-amino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-7,9-dihydro-8H-purin-8-one
• Synonyms: 6-amino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-7,9-dihydro-8H-purin-8-one
• CAS NO: 1361569-10-9
• Molecular Weight: 376.353
• Mol File: 1361569-10-9.mol

Chemical Properties

• CAS DataBase Reference: 6-amino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-7,9-dihydro-8H-purin-8-one(CAS DataBase Reference)
• NIST Chemistry Reference: 6-amino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-7,9-dihydro-8H-purin-8-one(1361569-10-9)
• EPA Substance Registry System: 6-amino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-7,9-dihydro-8H-purin-8-one(1361569-10-9)

Safety Data

• Hazardous Substances Data: 1361569-10-9(Hazardous Substances Data)

Upstream product

• 530-62-1 1,1'-carbonyldiimidazole 
• 428854-24-4 2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)pyrimidine-4,5,6- triamine 

Downstream Products

• 1361569-11-0 6-amino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-9-(²H₃)methyl-7,9-dihydro-8H-purin-8-one 
• 1361569-13-2 6-amino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-9-(2,2,2-trifluoroethyl)-7,9-dihydro-8H-purin-8-one 
• 1361569-12-1 6-amino-9-ethyl-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-7,9-dihydro-8H-purin-8-one 
• 1361569-16-5 6-amino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-9-isopropyl-7,9-dihydro-8H-purin-8-one 
• 1361569-15-4 6-Amino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-9-(2-methylprop-2-en-1-yl)-7,9-dihydro-8H-purin-8-one 
• 1361569-17-6 6-amino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-7-methyl-9-(2,2,2-trifluoroethyl)-7,9-dihydro-8H-purin-8-one 
• 1361569-14-3 6-amino-9-(cyclopropylmethyl)-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-7,9-dihydro-8H-purin-8-one 

Relevant articles and documents

BICYCLIC AZA HETEROCYCLES, AND USE THEREOF

The present application relates to novel bicyclic azaheterocycles, to processes for preparation thereof, to the use thereof, alone or in combinations, for treatment and/or prophylaxis of diseases and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially for treatment and/or prophylaxis of cardiovascular disorders.